Ontogeny of phosphoinositide 3-kinase signaling in developing heart: Effect of acute β-adrenergic stimulation

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 289, Issue 5 58-5, 2005, Pages

  Tseng, Yi Tang ^a   Yano, Naohiro ^a   Rojan, Adam ^a   Stabila, Joan P ^a   McGonnigal, Bethany G ^a   Ianus, Vlad ^a   Wadhawan, Rajan ^a   Padbury, James F ^a  

^a WOMEN AND INFANTS HOSPITAL   (United States)

Author keywords

Akt; Isoproterenol; Phosphoinositide dependent protein kinase 1; Proliferation, phosphatase and tensin homolog on chromosome 10

Indexed keywords

BETA ADRENERGIC RECEPTOR; ISOPRENALINE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN BCL 2; PROTEIN KINASE; PROTEIN KINASE B; S6 KINASE; SERINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; CELL HYPERPLASIA; CELL PROLIFERATION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; EMBRYO; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; GESTATIONAL AGE; HEART DEVELOPMENT; HEART MUSCLE CELL; HYPERTROPHIC CARDIOMYOPATHY; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADRENERGIC BETA-AGONISTS; AGING; ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; FEMALE; HEART; MYOCARDIUM; PHOSPHORYLATION; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 27144500964     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00435.2005     Document Type: Article

References (58)

1. Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P, and Hemmings BA. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 15: 6541-6551, 1996.
2. Alessi DR, Kozlowski MT, Weng QP, Morrice N, and Avruch J. 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro. Curr Biol 8: 69-81, 1998.
3. Auman JT, Seidler FJ, Tate CA, and Slotkin TA. Are developing β-adrenoceptors able to desensitize? Acute and chronic effects of β-agonists in neonatal heart and liver. Am J Physiol Regul Integr Comp Physiol 283: R205-R217, 2002.
4. Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, Bussani R, Nadal-Ginard B, Silvestri F, Leri A, Beltrami CA, and Anversa P. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 344: 1750-1757, 2001.
5. Bernal-Mizrachi E, Wen W, Stahlhut S, Welling CM, and Permutt MA. Islet β cell expression of constitutively active Akt1/PKBα induces striking hypertrophy, hyperplasia, and hyperinsulinemia. J Clin Invest 108: 1631-1638, 2001.
6. Bi L, Okabe I, Bernard DJ, Wynshaw-Boris A, and Nussbaum RL. Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110α subunit of phosphoinositide 3-kinase. J Biol Chem 274: 10963-10968, 1999.
7. 1-adrenergic receptor in transgenic mice. J Mol Cell Cardiol 32: 817-830, 2000.
8. Bonni A, Brunet A, West AE, Datta SR, Takasu MA, and Greenberg ME. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286: 1358-1362, 1999.
9. Boylan JM, Anand P, and Gruppuso PA. Ribosomal protein S6 phosphorylation and function during late gestation liver development in the rat. J Biol Chem 276: 44457-44463, 2001.
10. Brooks G, Poolman RA, McGill CJ, and Li JM. Expression and activities of cyclins and cyclin-dependent kinases in developing rat ventricular myocytes. J Mol Cell Cardiol 29: 2261-2271, 1997.
11. Buerke M, Murohara T, Skurk C, Nuss C, Tomaselli K, and Lefer AM. Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci USA 92: 8031-8035, 1995.
12. Cantley LC. The phosphoinositide 3-kinase pathway. Science 296: 1655-1657, 2002.
13. Caron MG and Lefkowitz RJ. Catecholamine receptors: structure, function, and regulation. Recent Prog Horm Res 48: 277-290, 1993.
14. Casamayor A, Morrice NA, and Alessi DR. Phosphorylation of Ser-241 is essential for the activity of 3-phosphoinositide-dependent protein kinase-1: identification of five sites of phosphorylation in vivo. Biochem J 342: 287-292, 1999.
15. 2-terminal kinase-dependent activation of the mitochondrial pathway. Circ Res 92: 136-138, 2003.
16. 2-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G protein. Circulation 100: 2210-2212, 1999.
17. Crackower MA, Oudit GY, Kozieradzki I, Sarao R, Sun H, Sasaki T, Hirsch E, Suzuki A, Shioi T, Irie-Sasaki J, Sah R, Cheng HY, Rybin VO, Lembo G, Fratta L, Oliveira-dos-Santos AJ, Benovic JL, Kahn CR, Izumo S, Steinberg SF, Wymann MP, Backx PH, and Penninger JM Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell 110: 737-749, 2002.
18. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, and Greenberg ME. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91: 231-241, 1997.
19. Datta SR, Ranger AM, Lin MZ, Sturgill JF, Ma YC, Cowan CW, Dikkes P, Korsmeyer SJ, and Greenberg ME. Survival factor-mediated BAD phosphorylation raises the mitochondrial threshold for apoptosis. Dev Cell 3: 631-643, 2002.
20. Engel FB, Schebesta M, Duong MT, Lu G, Ren S, Madwed JB, Jiang H, Wang Y, and Keating MT. p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev 19: 1175-1187, 2005.
21. Filardo EJ. Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer. J Steroid Biochem Mol Biol 80: 231-238, 2002.
22. Flotow H and Thomas G. Substrate recognition determinants of the mitogen-activated 70K S6 kinase from rat liver. J Biol Chem 267: 3074-3078, 1992.
23. Friddle CJ, Koga T, Rubin EM, and Bristow J. Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy. Proc Natl Acad Sci USA 97: 6745-6750, 2000.
24. Fujio Y, Nguyen T, Wencker D, Kitsis RN, and Walsh K. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 101: 660-667, 2000.
25. 1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells. Am J Physiol Cell Physiol 287: C281-C291, 2004.
26. Kim SO, Hasham MI, Katz S, and Pelech SL. Insulin-regulated protein kinases during postnatal development of rat heart. J Cell Biochem 71: 328-339, 1998.
27. Kudlacz EM, Navarro HA, Eylers JP, and Slotkin TA. Adrenergic modulation of cardiac development in the rat: effects of prenatal exposure to propranolol via continuous maternal infusion. J Dev Physiol 13: 243-249, 1990.
28. Kurosu H, Maehama T, Okada T, Yamamoto T, Hoshino S, Fukui Y, Ui M, Hazeki O, and Katada T. Heterodimeric phosphoinositide 3-kinase consisting of p85 and p110β is synergistically activated by the βγ-subunits of G proteins and phosphotyrosyl peptide. J Biol Chem 272: 24252-24256, 1997.
29. Laks MM and Morady F. Norepinephrine - the myocardial hypertrophy hormone? Am Heart J 91: 674-675, 1976.
30. Li F, Wang X, Capasso JM, and Gerdes AM. Rapid transition of cardiomyocytes from hyperplasia to hypertrophy during postnatal development. J Mol Cell Cardiol 28: 1737-1746, 1996.
31. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, and Parsons R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943-1947, 1997.
32. Liang J, Zubovitz J, Petrocelli T, Kotchetkov R, Connor MK, Han K, Lee JH, Ciarallo S, Catzavelos C, Beniston R, Franssen E, and Slingerland JM. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med 8: 1153-1160, 2002.
33. MacLellan WR and Schneider MD. Genetic dissection of cardiac growth control pathways. Annu Rev Physiol 62: 289-319, 2000.
34. Maehama T and Dixon JE. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273: 13375-13378, 1998.
35. Matsui T, Tao J, del Monte F, Lee KH, Li L, Picard M, Force TL, Franke TF, Hajjar RJ, and Rosenzweig A. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 104: 330-335, 2001.
36. 35a. Nienaber JJ, Tachibana H, Naga Prasad SV, Esposito G, Wu D, Mao L, and Rockman HA. Inhibition of receptor-localized PI3K preserves cardiac β-adrenergic receptor function and ameliorates pressure overload heart failure. J Clin Invest 112: 1067-1079, 2003.
37. Pearson RB, Dennis PB, Han JW, Williamson NA, Kozma SC, Wettenhall RE, and Thomas G. The principal target of rapamycin-induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain. EMBO J 14: 5279-5287, 1995.
38. 389 in p70 S6 kinase 1. J Biol Chem 277: 40281-40299, 2002.
39. Sasaki T, Irie-Sasaki J, Jones RG, Oliveira-dos-Santos AJ, Stanford WL, Bolon B, Wakeham A, Itie A, Bouchard D, Kozieradzki I, Joza N, Mak TW, Ohashi PS, Suzuki A, and Penninger JM. Function of PI3Kγ in thymocyte development, T cell activation, and neutrophil migration. Science 287: 1040-1046, 2000.
40. s6k gene reveals a small mouse phenotype and a new functional S6 kinase. EMBO J 17: 6649-6659, 1998.
41. Kip1 at threonine 157 and modulation of its cellular localization. Nat Med 8: 1145-1152, 2002.
42. Shioi T, Kang PM, Douglas PS, Hampe J, Yballe CM, Lawitts J, Cantley LC, and Izumo S. The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J 19: 2537-2548, 2000.
43. Shizukuda Y, Buttrick PM, Geenen DL, Borczuk AC, Kitsis RN, and Sonnenblick EH. β-Adrenergic stimulation causes cardiocyte apoptosis: influence of tachycardia and hypertrophy. Am J Physiol Heart Circ Physiol 275: H961-H968, 1998.
44. Slotkin TA, Auman JT, and Seidler FJ. Ontogenesis of β-adrenoceptor signaling: implications for perinatal physiology and for fetal effects of tocolytic drugs. J Pharmacol Exp Ther 306: 1-7, 2003.
45. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, and Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76-85, 1985.
46. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH, and Tavtigian SV. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15: 356-362, 1997.
47. Tolias KF, Rameh LE, Ishihara H, Shibasaki Y, Chen J, Prestwich GD, Cantley LC, and Carpenter CL. Type I phosphatidylinositol-4-phosphate 5-kinases synthesize the novel lipids phosphatidylinositol 3,5-bisphosphate and phosphatidylinositol 5-phosphate. J Biol Chem 273: 18040-18046, 1998.
48. Tseng YT, Kopel R, Stabila JP, McGonnigal BG, Nguyen TT, Gruppuso PA, and Padbury JF. β-adrenergic receptors (βAR) regulate cardiomyocyte proliferation during early postnatal life. FASEB J 15: 1921-1926, 2001.
49. Tuttle RL, Gill NS, Pugh W, Lee JP, Koeberlein B, Furth EE, Polonsky KS, Naji A, and Birnbaum MJ. Regulation of pancreatic β-cell growth and survival by the serine/threonine protein kinase Akt1/ PKBα. Nat Med 1: 1133-1137, 2001.
50. Vanhaesebroeck B and Waterfield MD. Signaling by distinct classes of phosphoinositide 3-kinases. Exp Cell Res 253: 239-254, 1999.
51. Vazquez F, Ramaswamy S, Nakamura N, and Sellers WR. Phosphorylation of the PTEN tail regulates protein stability and function. Mol Cell Biol 20: 5010-5018, 2000.
52. Kip1 by PKB/Akt-mediated phosphorylation in breast cancer. Nat Med 8: 1136-1144, 2002.
53. Ward SG and Finan P. Isoform-specific phosphoinositide 3-kinase inhibitors as therapeutic agents. Curr Opin Pharmacol 3: 426-434, 2003.
54. Wu X, Senechal K, Neshat MS, Whang YE, and Sawyers CL. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc Natl Acad Sci USA 95: 15587-15591, 1998.
55. Yamazaki T, Komuro I, Zou Y, Kudoh S, Shiojima I, Hiroi Y, Mizuno T, Aikawa R, Takano H, and Yazaki Y. Norepinephrine induces the raf-1 kinase/mitogen-activated protein kinase cascade through both CM- and β-adrenoceptors. Circulation 95: 1260-1268, 1997.
56. Zeiders JL, Seidler FJ, and Slotkin TA. Ontogeny of G-protein expression: control by β-adrenoceptors. Brain Res Dev Brain Res 120: 125-134, 2000.
57. L. Cell 87: 619-628, 1996.
58. 2-adrenergic signaling in adult mouse cardiac myocytes. Proc Natl Acad Sci USA 98: 1607-1612, 2001.